% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • michellefreed2000 michellefreed2000 Aug 1, 2013 1:59 PM Flag


    Anyone read about the article from Yahoo! Finance?

    "Under the terms of the transaction, Trius shareholders will receive $13.50 in cash for each share of Trius stock they own. Trius shareholders will also be eligible to receive one Contingent Value Right of up to $2.00 per share should certain commercial milestones be met. The investigation concerns whether the Trius Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether Cubist Pharmaceuticals, Inc. is underpaying for Trius, thus unlawfully harming Trius shareholders. In particular, at least one analyst set a price target for Trius stock at $20.00 per share.

    Hope you can share some input.

    SortNewest  |  Oldest  |  Most Replied Expand all replies